Neon Therapeutics
215 First Street
Cambridge
Massachusetts
02142
United States
Tel: 617-337-4701
Website: http://neontherapeutics.com/
Email: info@neontherapeutics.com
About Neon Therapeutics
NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.
YEAR FOUNDED:
2015
LEADERSHIP:
Founders: James Allison, Ed Fritsch, Nir Hacohen, and Eric Lander
CEO: Hugh O'Dowd
CBO: Robert Ang
CTO: ED Fritsch
CMO: Barbara Weber
CFO: Daniella Beckman
JOBS:
Please click here for Neon job opportunities.
51 articles about Neon Therapeutics
-
Vedantra Announces A Joint Research Collaboration With Neon Therapeutics To Develop Cancer Vaccines
3/14/2017
-
Neon Therapeutics Release: Using Mono-Allelic Mass Spectrometry Data To Improve Epitope Prediction Algorithms Published In Immunity
2/21/2017
-
What You Need to Know About Neon Therapeutics
1/12/2017
-
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
-
Massachusetts Startup Neon Therapeutics Rakes in $70 Million for Personalized Cancer Vaccines
1/5/2017
-
Neon Therapeutics Announces First Patient Enrolled In Inaugural Clinical Trial For Personalized Cancer Vaccine NEO-PV-01
11/17/2016
-
Neon Therapeutics Appoints Dr. Richard Gaynor To President Of Research And Development
11/7/2016
-
Neon Therapeutics Taps Former Novartis AG Cancer Vet as New CEO
9/27/2016
-
Neon Therapeutics Announces FDA Acceptance Of Investigational New Drug Application For Cancer Vaccine NEO-PV-01
7/29/2016
-
Neon Therapeutics Enters Collaborative Research Agreement With The Netherlands Cancer Institute (NCI)
2/23/2016
-
Neon Therapeutics Enters License Agreement With Sanquin Blood Supply Foundation For Peptide-MHC Assay Technology
2/17/2016